Learn More
Eurofins Discoverx Ret (V804L), active, 250 µg. (14-758M)
Supplier: Eurofins Discoverx 14758M
N-terminal GST-tagged recombinant, human Ret amino acids 658-end containing the V804L mutation. The V804L mutation has been identified in patients with familial medullary thyroid carcinoma (FMTC) (Lombardo F. et al., (2002), JCEM, 87, 1674-1680; Lesueur F. et al, (2005), JCEM, 90, 3454-3457). For detailed product information, visit www.discoverx.com/proteins.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.